Deutsche Bank AG purchased a new position in shares of CME Group Inc. (NASDAQ:CME – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,494,948 shares of the financial services provider’s stock, valued at approximately $330,129,000. Deutsche Bank AG owned approximately 0.42% of CME Group as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently made changes to their positions in the company. Empowered Funds LLC lifted its holdings in CME Group by 11.5% in the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after buying an additional 1,037 shares during the period. Marshall Wace LLP increased its holdings in shares of CME Group by 103.1% during the second quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock valued at $1,018,000 after acquiring an additional 121,707 shares in the last quarter. Federated Hermes Inc. lifted its stake in shares of CME Group by 1,325.2% in the second quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock worth $6,497,000 after buying an additional 21,918 shares in the last quarter. Nebula Research & Development LLC bought a new stake in shares of CME Group in the 2nd quarter worth $992,000. Finally, The Manufacturers Life Insurance Company raised its position in CME Group by 2.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock worth $79,344,000 after buying an additional 7,397 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of analysts recently commented on the company. Erste Group Bank cut CME Group from a “buy” rating to a “hold” rating in a research report on Friday, June 5th. Keefe, Bruyette & Woods raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price for the company in a report on Thursday, June 18th. UBS Group cut their price objective on shares of CME Group from $310.00 to $260.00 and set a “buy” rating for the company in a report on Monday, July 6th. TD Cowen cut their price objective on CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a research report on Monday, June 22nd. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on shares of CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research note on Thursday, April 23rd. Ten equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $291.81.
Insider Buying and Selling
In other CME Group news, Director William R. Shepard purchased 325 shares of CME Group stock in a transaction dated Thursday, June 25th. The stock was acquired at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the acquisition, the director owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.30% of the company’s stock.
CME Group Price Performance
CME opened at $267.88 on Tuesday. The business has a fifty day moving average of $250.51 and a 200 day moving average of $280.07. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a market cap of $96.32 billion, a P/E ratio of 22.72, a PEG ratio of 3.14 and a beta of 0.23. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16.
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping the consensus estimate of $2.91 by $0.08. The company had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm’s revenue was up .8% compared to the same quarter last year. During the same quarter last year, the firm posted $2.96 EPS. As a group, sell-side analysts anticipate that CME Group Inc. will post 12.27 EPS for the current year.
CME Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be given a dividend of $1.30 per share. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s dividend payout ratio is presently 44.11%.
About CME Group
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Stories
- Five stocks we like better than CME Group
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
